- Investigator
- Alaa S Awad
- Ages
- 18 Years - N/A
- Sexes
- All
Clinical trials
-
The TwoPlus Study-Comparative Effectiveness of an Individualized Model of Hemodialysis vs. Conventional Hemodialysis -
DAPA-HF ACT - Investigator
- Francesco Franchi
- Ages
- 18 Years - N/A
- Sexes
- All
-
Double Blind Placebo-Controlled Parallel Group Study of Safety and Efficacy of Isomyosamine in Treating Sarcopenia After Hip or Femoral Fracture in Gerontological Population - Investigator
- Porter F Young
- Ages
- 60 Years - 85 Years
- Sexes
- All
-
Study of BD ORC Original Absorbable Hemostat Compared with Surgicel簧 Original Absorbable Hemostat - Investigator
- Kethandapatti Balaji
- Ages
- 22 Years - 101 Years
- Sexes
- All
-
A Multi-Center Phase 2/3 Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Safety and Efficacy Study of Dapansutrile Tablets in Subjects with an Acute Gout Flare - Investigator
- Gurjit S Kaeley
- Ages
- 18 Years - 100 Years
- Sexes
- All
-
ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke - Investigators
- Benjamin T Alwood, Scott L Silliman
- Ages
- 18 Years - 90 Years
- Sexes
- All
-
ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke - Investigators
- Benjamin T Alwood, Scott L Silliman
- Ages
- 18 Years - 90 Years
- Sexes
- All
-
Open-Label, Phase 2, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of Patiromer in Children under 12 Years of Age with Hyperkalaemia - Investigator
- Mohammad Ilyas
- Ages
- 0 Years - 12 Years
- Sexes
- All